Navigation Links


Sphingomab in Medical Technology

Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab

Sphingomab Shows Near-Complete Mitigation of Choroidal Neovascularization (CNV) in an AMD Model SAN DIEGO, May 22, 2007 /PRNewswire-FirstCall/ -- Lpath, Inc. , the category leader in therapeutic agents against bioactive lipids, reported compelling proof-of-concept data in a standard animal model o...

Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process

...ing with them again on our Lpathomab project." This achievement with Lpathomab comes on the heels of Lpath's success with its Sphingomab(TM) program. sphingomab is an antibody against another bioactive lipid, S1P. Lpath humanized the antibody in 2006 and plans to file an IND in November of this year for the us...

Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates

...udy included evaluation of the effect of humanized sphingomab treatment on blood pressure, heart rate, and respi...r, cytokine release, and ADCC tests with humanized sphingomab were all negative at doses or concentrations well ...y featured intravenous administration of humanized sphingomab at doses as great as 100 mg/kg every three days fo...
Sphingomab in other areas

About - Business & Finance - MEDIAVIEWER

Sphingomab is potently anti-angiogenic, yet it has other ... As such, Lpath believes Sphingomab may represent the next ... Sphingomab is a trademark ...

PipelineReview.com - Biotech News & Online Store - Lpath Humanizes Its ...

... Biopharmaceutical Industry, Lpath Humanizes Its Anti-S1P Antibody Sphingomab(TM) ... murine (mouse-based) form of Sphingomab was the first antibody created ...

PipelineReview.com - Biotech News & Online Store - Lpath Demonstrates ...

... Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM... Sphingomab, generated by Lpath's proprietary ImmuneY2(TM) platform ...

Novel Drug Stops Cancer Growth

A first-of-its-kind drug effectively targets a molecule that fuels cancer cells and shows promise for stopping the ... Sphingomab is a monoclonal antibody. ...

Lpath granted patent protection for anti-cancer anti-S1P antibody.

Lpath, Inc. (San Diego, CA) , the category leader in therapeuticagents against bioactive lipids, announced the issuance ... Sphingomab is potently anti ...
Other TagsHolter
(Date:11/27/2009)...INE, France, Nov. 27 Team Garmin-S... team dedicated to ethical sporting and developing...ed today that it will become Team Garmin-Transitio...ew sponsor of the team. Transitions Optical is the... offering the most advanced photochromic technolog...
(Date:11/27/2009)...-emission vehicles may reduce future disease burde...HealthDay News) -- Encouraging city dwellers to wa...uch greater public health benefits than increased ...ve found. , The study compared the projected he...nsport scenarios for London, England, and Delhi, I...
(Date:11/27/2009)...yant Health™ announced today that Spectrum H...aumaCad Enterprise orthopedic templating solution ... (PRWEB) November 27, 2009 -- ... Health (Grand Rapids, Michigan) has licensed its ...n and its TraumaCad Extend workflow solution, to a...
(Date:11/27/2009)...ree new interactive anatomy education apps from Mo...d health sciences learning opportunities for iPhon..., NC (Vocus) November 27, 2009 -- Modality, Inc. ...vision of Wolters Kluwer Health, today announced t...s on the App Store. Clemente’s Anatomy, Rohe...
(Date:11/26/2009)...number of Americans living with diabetes will near... 44.1 million in 2034. Over the same period, spend...13 billion to $336 billion, even with no increase ... the University of Chicago report in the December ...with diabetes covered by Medicare will rise from 8...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
(Date:11/26/2009)...countries has shown that closing schools in the ev... significant role in reducing illness transmission...BMC Infectious Diseases compared opportunities fo...finding that they were reduced when schools are sh...sity, Belgium, led a team of European researchers ...
(Date:11/26/2009)...ccus Aureus ) and other drug-resistant bacteria co...ototype devices have been developed to offer safe,... , Two prototype devices have been developed: on... hands and feet) in hospitals and public spaces wh... to shoot bacteria-killing agents into infested ch...
(Date:11/25/2009)...ives. In addition to mammalian immune systems that...d bacteriophages, viruses that kill half the bacte...and another class of microorganisms called archaea... deep-sea volcanic vents) manage just fine, thank ...system that helps protect them from many viruses a...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Ventilation After Breathing Tube Removal May Alter Outcomes 54416 1Ventilation After Breathing Tube Removal May Alter Outcomes 54416 2MRI May Not Improve Breast Cancer Outcome 54414 1China Medicine Announces Second Quarter 2009 Results 54412 1China Medicine Announces Second Quarter 2009 Results 54412 2China Medicine Announces Second Quarter 2009 Results 54412 3China Medicine Announces Second Quarter 2009 Results 54412 4China Medicine Announces Second Quarter 2009 Results 54412 5China Medicine Announces Second Quarter 2009 Results 54412 6China Medicine Announces Second Quarter 2009 Results 54412 7China Medicine Announces Second Quarter 2009 Results 54412 8China Medicine Announces Second Quarter 2009 Results 54412 9China Medicine Announces Second Quarter 2009 Results 54412 10China Medicine Announces Second Quarter 2009 Results 54412 11China Medicine Announces Second Quarter 2009 Results 54412 12China Medicine Announces Second Quarter 2009 Results 54412 13China Medicine Announces Second Quarter 2009 Results 54412 14
Other Contentscompositecompositecompositecompositecompositecompositecomplementationcomplementationcompletecompletecompletecompletecompletecompletecompletecompletecompletecompletecompoundcompoundcompoundcompoundcompoundcompoundcompoundcompoundcompoundcomputationalcomputationalcomputationalcomputationalcomputationalconcentrationconcentrationconcentrationconcentrationconcentrationconcentrationconcentrationconcentrationconcentrationconeconeconeconecone